Key Insights

Highlights

Success Rate

90% trial completion (above average)

Published Results

54 trials with published results (29%)

Research Maturity

117 completed trials (62% of total)

Clinical Risk Assessment

Based on trial outcomes

Low Risk

Score: 17/100

Termination Rate

6.9%

13 terminated out of 189 trials

Success Rate

90.0%

+3.5% vs benchmark

Late-Stage Pipeline

28%

52 trials in Phase 3/4

Results Transparency

46%

54 of 117 completed with results

Key Signals

54 with results90% success13 terminated

Data Visualizations

Phase Distribution

143Total
Not Applicable (71)
Early P 1 (1)
P 1 (5)
P 2 (14)
P 3 (21)
P 4 (31)

Trial Status

Completed117
Unknown22
Recruiting16
Terminated13
Active Not Recruiting11
Withdrawn5

Trial Success Rate

90.0%

Benchmark: 86.5%

Based on 117 completed trials

Clinical Trials (189)

Showing 20 of 20 trials
NCT03798223Not ApplicableActive Not RecruitingPrimary

Optimal Treatment Protocol for Selective Laser Trabeculoplasty

NCT07698353Not ApplicableActive Not RecruitingPrimary

A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent

NCT06964191Phase 2Active Not RecruitingPrimary

Evaluate Efficacy and Safety of PA5108 Ocular Implants in Primary Open Angle Glaucoma or Ocular Hypertension

NCT06240312Not ApplicableActive Not RecruitingPrimary

Optic Nerve Head Strain as Biomarker for Glaucoma

NCT06066645Phase 4RecruitingPrimary

Travoprost Intraocular Implant + iStent Infinite

NCT04702789Phase 4TerminatedPrimary

Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.

NCT05236439Not ApplicableCompletedPrimary

Study of a Cilioscleral Interposition Device (CID) SV22 in Patients With Primary Open Angle Glaucoma and Narrow Angle Glaucoma

NCT05626491Not ApplicableActive Not Recruiting

Electrical Stimulation for the Treatment of Glaucoma

NCT05625958Not ApplicableActive Not RecruitingPrimary

Clinical Study Evaluating the Efficacy and Safety of CID v2.2 in Glaucoma Surgery

NCT06689696Completed

24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring

NCT06289491Not ApplicableRecruiting

A Trial of Hydrus Microstent Versus Goniotomy

NCT07486323Not ApplicableNot Yet RecruitingPrimary

Combined Non-Invasive Brain and Visual Stimulation for Vision Improvement

NCT06848946Phase 4RecruitingPrimary

Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone

NCT06058598Not ApplicableActive Not RecruitingPrimary

Exercise Training in Patients With Glaucoma

NCT05885022Not ApplicableRecruitingPrimary

Feasibility Clinical Evaluation of the Calibreye System

NCT05325996Not ApplicableCompletedPrimary

Evaluating Home Testing Devices for the Management of Glaucoma

NCT06685211Not ApplicableRecruiting

Electrical Stimulation for Vision Neuroenhancement in Glaucoma

NCT04658095Not ApplicableTerminatedPrimary

Study of OMNI Surgical System and iStent for Eyes With OAG (Trident)

NCT04770324Not ApplicableTerminatedPrimary

Study of a Novel Interposition Supraciliary Implant in Patients With Open Angle Glaucoma (SAFARI 2)

NCT04007276Phase 4Not Yet Recruiting

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

Scroll to load more

Research Network

Activity Timeline